Institutional Ownership
Halozyme Therapeutics Inc
CUSIP 40637HAF6NOTE 1.000% 8/1HALOQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
8
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Absolute Investment Advisers, LLC | 14.00M | $17.95M |
| 2 | Ssi Investment Management LLC | 6.08M | $7.78M |
| 3 | Ofi Invest Asset Management | 6.80M | $7.60M |
| 4 | State Of Wisconsin Investment Board | 3.00M | $3.84M |
| 5 | Focus Partners Wealth | 2.29M | $2.96M |
| 6 | Boussard & Gavaudan Investment Management LLP | 2.1K | $2.67M |
| 7 | Bank Of New York Mellon Corp | 610.0K | $785.5K |
| 8 | Loomis Sayles & Co L P | 5.2K | $334.6K |